Jubilant Pharmova Statistics

Total Valuation

Jubilant Pharmova has a market cap or net worth of INR 149.29 billion. The enterprise value is 169.19 billion.

Market Cap	149.29B
Enterprise Value	169.19B

Important Dates

The next estimated earnings date is Friday, January 31, 2025.

Earnings Date	Jan 31, 2025
Ex-Dividend Date	Aug 2, 2024

Share Statistics

Jubilant Pharmova has 158.35 million shares outstanding. The number of shares has decreased by -0.03% in one year.

Current Share Class	n/a
Shares Outstanding	158.35M
Shares Change (YoY)	-0.03%
Shares Change (QoQ)	+0.18%
Owned by Insiders (%)	7.67%
Owned by Institutions (%)	14.29%
Float	55.86M

Valuation Ratios

The trailing PE ratio is 25.26 and the forward PE ratio is 30.69. Jubilant Pharmova's PEG ratio is 0.52.

PE Ratio	25.26
Forward PE	30.69
PS Ratio	2.16
PB Ratio	2.52
P/TBV Ratio	6.25
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	0.52

Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 16.52, with an EV/FCF ratio of -61.66.

EV / Earnings	28.53
EV / Sales	2.45
EV / EBITDA	16.52
EV / EBIT	24.16
EV / FCF	-61.66

Financial Position

The company has a current ratio of 1.80, with a Debt / Equity ratio of 0.52.

Current Ratio	1.80
Quick Ratio	0.98
Debt / Equity	0.52
Debt / EBITDA	3.14
Debt / FCF	-11.23
Interest Coverage	2.52

Financial Efficiency

Return on equity (ROE) is 10.40% and return on invested capital (ROIC) is 4.54%.

Return on Equity (ROE)	10.40%
Return on Assets (ROA)	3.52%
Return on Capital (ROIC)	4.54%
Revenue Per Employee	12.82M
Profits Per Employee	1.10M
Employee Count	5,399
Asset Turnover	0.59
Inventory Turnover	1.92

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +64.42% in the last 52 weeks. The beta is 1.59, so Jubilant Pharmova's price volatility has been higher than the market average.

Beta (5Y)	1.59
52-Week Price Change	+64.42%
50-Day Moving Average	1,105.73
200-Day Moving Average	924.80
Relative Strength Index (RSI)	42.08
Average Volume (20 Days)	12,478

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Jubilant Pharmova had revenue of INR 69.20 billion and earned 5.93 billion in profits. Earnings per share was 37.33.

Revenue	69.20B
Gross Profit	45.29B
Operating Income	6.57B
Pretax Income	6.91B
Net Income	5.93B
EBITDA	9.23B
EBIT	6.57B
Earnings Per Share (EPS)	37.33

Full Income Statement

Balance Sheet

The company has 10.77 billion in cash and 30.80 billion in debt, giving a net cash position of -20.03 billion or -126.49 per share.

Cash & Cash Equivalents	10.77B
Total Debt	30.80B
Net Cash	-20.03B
Net Cash Per Share	-126.49
Equity (Book Value)	59.27B
Book Value Per Share	373.88
Working Capital	15.55B

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 7.68 billion and capital expenditures -10.42 billion, giving a free cash flow of -2.74 billion.

Operating Cash Flow	7.68B
Capital Expenditures	-10.42B
Free Cash Flow	-2.74B
FCF Per Share	-17.33

Full Cash Flow Statement

Margins

Gross margin is 65.46%, with operating and profit margins of 9.49% and 8.57%.

Gross Margin	65.46%
Operating Margin	9.49%
Pretax Margin	9.99%
Profit Margin	8.57%
EBITDA Margin	13.34%
EBIT Margin	9.49%
FCF Margin	n/a

Dividends & Yields

This stock pays an annual dividend of 5.00, which amounts to a dividend yield of 0.51%.

Dividend Per Share	5.00
Dividend Yield	0.51%
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	13.42%
Buyback Yield	0.03%
Shareholder Yield	0.54%
Earnings Yield	3.96%
FCF Yield	-1.84%

Dividend Details

Stock Splits

The last stock split was on March 17, 2006. It was a forward split with a ratio of 5.

Last Split Date	Mar 17, 2006
Split Type	Forward
Split Ratio	5

Scores

Altman Z-Score	n/a
Piotroski F-Score	n/a